Chirin Yekrangi-Hartmann

Title: Innovations by Chirin Yekrangi-Hartmann in Cough Treatment

Introduction

Chirin Yekrangi-Hartmann is an accomplished inventor based in Mettmann, Germany. Known for his innovative contributions to the field of pharmaceuticals, he has developed promising solutions for health-related issues. His notable achievement includes a patent focused on treating nonproductive coughs through the use of non-steroidal anti-inflammatory drugs.

Latest Patents

Yekrangi-Hartmann holds one patent titled "Non-steroidal anti-inflammatory drugs for cough." This patent outlines the use of a non-steroidal anti-inflammatory drug for the treatment of nonproductive cough caused by viruses or bacteria. Moreover, it details a formulation that combines at least one non-steroidal anti-inflammatory drug with at least one antitussive to effectively manage cough symptoms.

Career Highlights

Currently, Yekrangi-Hartmann is employed at Bayer Consumer Care AG, a leading company in the healthcare and consumer products sector. His work at Bayer allows him to contribute significantly to the development of innovative health solutions aimed at improving patient care and therapeutic outcomes.

Collaborations

Throughout his career, Chirin has collaborated with several accomplished professionals, including Marianne Petersen-Braun and Uwe Gessner. These collaborations emphasize the importance of teamwork in advancing research and innovation in the pharmaceutical industry.

Conclusion

Chirin Yekrangi-Hartmann's contributions to pharmaceutical innovation demonstrate his commitment to improving treatments for common health issues. His patented formulation for treating nonproductive cough showcases the potential of combining various therapeutic agents for enhanced efficacy. As he continues to work at Bayer Consumer Care AG, it will be exciting to see how his future endeavors in the field unfold.